Results 81 to 90 of about 87,373,768 (197)

Knowledge, experiences, and perceptions of medications for opioid use disorder among Black Kentuckians

Annals of Medicine
Background Opioid overdoses have continued to increase at higher rates among Black Americans compared to people from other racial groups. Despite demonstrated effectiveness of MOUD in reducing risk of opioid overdose, Black Americans face decreased ...
Paris B. Wheeler, Brittany Miller-Roenigk, Jasmine Jester, Danelle Stevens-Watkins   +3 more
doaj   +1 more source

Perinatal healthcare experiences of pregnant and parenting people with a history of substance use disorder: a qualitative study

BMC Pregnancy and Childbirth
Background Clinical guidelines in the United States (U.S.) recommend a patient-centered approach to healthcare for pregnant people with substance use disorders (SUD); however, pregnant people with SUD often describe experiencing stigmatization and shame ...
Carol Y. Franco-Rowe, Angela E. Lee-Winn, Venice Ng Williams, Connie Lopez, Gregory J. Tung, Mandy A. Allison   +5 more
doaj   +1 more source

A Review of Pharmacotherapy in Opioid Use Disorder

, 2022
This article serves as a brief pharmacological review of the most common medications used in the treatment of Opioid Use Disorder (OUD), their pharmacokinetics, efficacy, and access so that providers may use this as a quick resource of ...
Davis, Bennicia
core   +1 more source

A self-assessment of opioid use disorder services at a Pacific Northwest County jail

Substance Abuse Treatment, Prevention, and Policy
This study describes the delivery of opioid use disorder (OUD) services in a Pacific Northwest County jail focusing on screening, assessment, withdrawal management, and medications for opioid use disorder (MOUD).
Joseph E. Schumacher, Scott A. Bell, Abdullah Ahsan, Phillip R. Cochran, Allan G. Gutierrez, Emma R. Morris, Bradley J. Cain   +6 more
doaj   +1 more source

Stress-evoked opioid release inhibits pain in major depressive disorder [PDF]

, 2008
To determine whether stress-evoked release of endogenous opioids might account for hypoalgesia in major depressive disorder (MDD), the μ-opioid antagonist naltrexone (50 mg) or placebo was administered double-blind to 24 participants with MDD and to 31 ...
Frew, A.K., Drummond, P.D.
core  

Patient and clinician experiences with the implementation of telemedicine and related adaptations in office-based buprenorphine treatment during the COVID-19 pandemic: a qualitative study

Addiction Science & Clinical Practice
Background Deaths from opioid overdose have increased dramatically in the past decade. For individuals with opioid use disorder (OUD), agonist medications such as methadone and buprenorphine reduce opioid-related morbidity and mortality.
Melissa Davoust, Angela R. Bazzi, Samantha Blakemore, Juliana Blodgett, Anna Cheng, Sarah Fielman, Kara M. Magane, Jacqueline Theisen, Richard Saitz, Alicia S. Ventura, Zoe M. Weinstein   +10 more
doaj   +1 more source

Induction of Medication for Opioid Use Disorder in Primary Care

The Journal of the American Board of Family Medicine
Overdoses and deaths from synthetic opioids grew sharply in the past decade. Most people with opioid use disorder (OUD) do not receive recommended evidence-based treatment: nationally, 72% to 87% of people who need OUD treatment do not receive medication for opioid use disorder (MOUD). Little is known about practice teams' experiences with home, office,
Hall, Tristen L., Fernald, Douglas H., Jiang, Vivian, Curcija, Kristen, LeMaster, Joseph W., Westfall, John M., Nease, Donald E., Zittleman, Linda   +7 more
openaire   +3 more sources

Use of a Decision Aid in Medication Initiation Among Patients with Opioid Use Disorder and HIV [PDF]

, 2023
Opioid use disorder refers to the maladaptive use of prescribed or illicit opioids. This condition can be treated using pharmacotherapy referred to as medications for opioid use disorder (MOUD), but they are underutilized.
Gateley, Katrina
core  

A mixed-method exploratory assessment of provider-based stigma of opioid use disorder (OUD) and support for medications for opioid use disorder (MOUD) in carceral settings

Harm Reduction Journal
Background In 2019, the state of Maryland passed legislation requiring local detention centers to offer medications for opioid use disorder (MOUD) to all incarcerated individuals who met criteria for opioid use disorder (OUD).
Katherine J. McLean, Nathan E. Kruis, Eric Weintraub, Heather Fitzsimons, Christopher Welsh, Natalie Spicyn, Brook Kearley, William Altekruse, Nicholas Rowland, Annabelle Belcher   +9 more
doaj   +1 more source

Novel therapeutic and program-based approaches to opioid use disorders.

Opioid use disorder continues to drive overdose deaths in many countries, including the United States. Illicit fentanyl and its analogues have emerged as key contributors to the complications and mortality associated with opioid use disorder. Medications
Buchheit, Bradley M, Korthuis, P Todd, Liu, Patricia   +2 more
core   +1 more source